Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

TWST

Twist Bioscience Corp

Feb 04 • 04:00PM ET

52.02

Dollar change -0.73
Percentage change -1.38	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN PACB CRSP EDIT NTLA BEAM SGMO AMGN REGN BIIB

| Held by: ARKK ARKG IWM VTI VB XBI VXF VBK IWO IBB

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.38	Insider Own	5.56%	Shs Outstand	59.58M	Perf Week	0.31%
Market Cap	3.10B	Forward P/E	-	EPS next Y	-1.50	Insider Trans	-4.04%	Shs Float	56.27M	Perf Month	14.81%
Income	-197.31M	PEG	-	EPS next Q	-0.55	Inst Own	109.88%	Short Float	16.31%	Perf Quarter	28.89%
Sales	330.19M	P/S	9.39	EPS this Y	43.45%	Inst Trans	6.63%	Short Ratio	10.84	Perf Half Y	21.06%
Book/sh	7.65	P/B	6.80	EPS next Y	26.28%	ROA	-29.42%	Short Interest	9.18M	Perf Year	56.40%
Cash/sh	4.55	P/C	11.44	EPS next 5Y	-	ROE	-37.73%	52W Range	27.41 - 60.90	Perf YTD	11.94%
Dividend Est.	-	P/FCF	-	EPS past 5Y	1.70%	ROI	-37.69%	52W High	-14.58%	Beta	2.10
Dividend TTM	-	Quick Ratio	4.62	Sales past 5Y	42.89%	Gross Margin	44.59%	52W Low	89.78%	ATR (14)	3.53
Dividend Ex-Date	-	Current Ratio	4.96	EPS Y/Y TTM	6.06%	Oper. Margin	-49.54%	RSI (14)	57.63	Volatility	8.60% 7.11%
Employees	923	Debt/Eq	0.18	Sales Y/Y TTM	25.85%	Profit Margin	-59.76%	Recom	1.77	Target Price	55.82
Option/Short	Yes / Yes	LT Debt/Eq	0.15	EPS Q/Q	28.61%	Payout	-	Rel Volume	0.98	Prev Close	52.75
Sales Surprise	2.01%	EPS Surprise	15.13%	Sales Q/Q	24.08%	Earnings	Feb 03 BMO	Avg Volume	846.81K	Price	52.02
SMA20	6.15%	SMA50	7.80%	SMA200	13.51%	Trades		Volume	825,981	Change	-1.38%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Jun-04-24	Initiated	Guggenheim	Buy	$53
Jan-17-24	Upgrade	Goldman	Neutral → Buy	$25 → $45
Sep-27-23	Initiated	Berenberg	Buy	$27
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$33
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform	$28 → $36
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral	$110
Apr-12-21	Initiated	Piper Sandler	Overweight	$150
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight	$100
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform	$90
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral	$27

Show Previous Ratings

Today 02:01AM	Twist Bioscience Corp (TWST) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
12:47AM	Q1 2025 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-03-25 08:25AM	Twist Bioscience (TWST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:25AM	Twist Bioscience: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results (Business Wire)
07:05AM	Loading…
Jan-31-25 07:05AM	Twist Bioscience Corp (TWST) Q1 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
Jan-22-25 08:00AM	Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025 (Business Wire)
Dec-27-24 12:00PM	All You Need to Know About Twist Bioscience (TWST) Rating Upgrade to Buy (Zacks)
Dec-23-24 08:48AM	Twist Bioscience (TWST) Surges 9.9%: Is This an Indication of Further Gains? (Zacks)
Dec-19-24 08:00AM	Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-16-24 09:55AM	Twist Bioscience (TWST) Could Find a Support Soon, Here's Why You Should Buy the Stock Now (Zacks)
Dec-11-24 11:59AM	Why Twist Bioscience (TWST) Is the Worst ARK Stock to Buy According to Short Sellers (Insider Monkey) -5.24%
Nov-27-24 07:30AM	Twist Bioscience named a Best Idea for 2025 at TD Cowen (TipRanks)
Nov-20-24 09:15AM	AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care (PR Newswire)
Nov-19-24 09:15PM	Twist Bioscience price target lowered to $52 from $55 at Barclays (TipRanks)
06:49PM	Loading…
06:49PM	Twist Bioscience Corporation (TWST): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey)
02:33AM	Q4 2024 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
02:02AM	Twist Bioscience Corp (TWST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
Nov-18-24 12:17PM	Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps (Benzinga) +12.31%
08:25AM	Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:33AM	Twist Bioscience: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results (Business Wire)
Nov-15-24 10:44PM	Twist Bioscience Corp (TWST) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com) -5.31%
Nov-14-24 08:00AM	Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference (Business Wire) -8.31%
Nov-07-24 04:05PM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Oct-31-24 08:00AM	Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI (GlobeNewswire) -6.53%
Oct-30-24 08:00AM	Twist Bioscience Launches FlexPrep Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics (Business Wire)
Oct-24-24 08:00AM	Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024 (Business Wire)
Oct-22-24 08:00AM	Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash (Business Wire)
Oct-15-24 08:00AM	Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer (Business Wire)
08:00AM	Loading…
Sep-12-24 08:00AM	Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance (Business Wire)
Sep-09-24 08:00AM	Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels (Business Wire)
Sep-08-24 03:55PM	Twist Bioscience Corporation (TWST): Among the Worst ARK Stocks According to Short Sellers (Insider Monkey)
11:49AM	10 Worst ARK Stocks To Buy According To Short Sellers (Insider Monkey)
Aug-27-24 08:00AM	Twist Bioscience to Present at Baird Global Healthcare Conference 2024 (Business Wire)
Aug-14-24 09:45AM	How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates (GlobeNewswire)
Aug-08-24 08:00AM	Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb (Business Wire)
Aug-07-24 06:47AM	3 Healthcare AI Stocks Positioned for Potential Breakthroughs (InvestorPlace)
Aug-06-24 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Aug-05-24 11:20AM	The 3 Best Med Tech Stocks to Buy Now (InvestorPlace) +5.49%
08:00AM	Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis (Business Wire)
Aug-02-24 08:40AM	Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -19.00%
07:37AM	Twist Bioscience: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results (Business Wire)
Jul-30-24 02:17AM	Is Twist Bioscience Corporation (TWST) in the Pole Position? (Insider Monkey)
Jul-26-24 10:00AM	Twist Bioscience (TWST) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Jul-18-24 08:00AM	Twist Bioscience Announces Clinical Progression of Pure Biologics Antibody Candidate Discovered Using Twists Antibody Libraries (Business Wire)
Jul-11-24 08:00AM	Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024 (Business Wire)
Jul-10-24 08:00AM	Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies (Business Wire)
Jul-09-24 08:00AM	Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A (Business Wire)
Jul-01-24 07:08PM	Is Twist Bioscience Corporation (TWST) a Good Stock to Buy and Hold for 5 Years? (Insider Monkey)
02:31PM	10 Best Stocks to Buy and Hold For 5 Years According to Cathie Wood (Insider Monkey)
Jun-06-24 08:00AM	Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor (Business Wire)
Jun-04-24 08:00AM	Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety (Business Wire) +6.75%
May-24-24 04:58PM	IBD 50 Stock Reverses Badly As Weight-Loss Boost Fades Fast; Cathie Wood Stock Falls Hard (Investor's Business Daily)
May-23-24 08:00AM	Twist Bioscience to Present at Upcoming Investor Conferences (Business Wire)
May-22-24 12:00PM	What Makes Twist Bioscience (TWST) a Strong Momentum Stock: Buy Now? (Zacks)
May-13-24 08:00AM	Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications (Business Wire) +11.94%
May-10-24 06:00AM	Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life (InvestorPlace)
May-08-24 08:00AM	Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
May-03-24 03:55PM	Sector Update: Health Care Stocks Mixed Late Afternoon (MT Newswires) +28.74%
01:58PM	Sector Update: Health Care Stocks Mixed in Afternoon Trading (MT Newswires)
01:22PM	Twist Bioscience Shares Jump After Fiscal Q2 Beat, Fiscal 2024 Revenue Guidance Raised (MT Newswires)
10:02AM	Twist Bioscience Corporation (NASDAQ:TWST) Q2 2024 Earnings Call Transcript (Insider Monkey)
06:47AM	Q2 2024 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
04:05AM	Twist Bioscience Corp (TWST) Q2 2024 Earnings Call Transcript Highlights: Key Financial ... (GuruFocus.com)
May-02-24 09:00PM	TWST Stock Earnings: Twist Bioscience Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
05:35PM	Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:33PM	Twist Bioscience: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results (Business Wire)
Apr-30-24 03:20PM	3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition (InvestorPlace)
Apr-25-24 11:31AM	5 Fastest Growing Health Tech Companies in the World (Insider Monkey)
Apr-18-24 08:00AM	Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024 (Business Wire)
Mar-28-24 08:00AM	Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations (Business Wire)
Mar-05-24 08:00AM	Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing (Business Wire)
Feb-22-24 08:00AM	Twist Bioscience to Present at Upcoming Investor Conferences (Business Wire)
Feb-13-24 01:59PM	7 Stocks Cathie Wood Is Still Loading Up On in Q1 (InvestorPlace) -8.86%
Feb-10-24 05:28AM	Twist Bioscience Corp Director Robert Chess Sells 4,110 Shares (GuruFocus.com)
Feb-07-24 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire) -5.41%
Feb-06-24 08:05AM	Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System (Business Wire)
08:00AM	Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications (Business Wire)
Feb-05-24 08:09AM	Twist Bioscience Corporation (NASDAQ:TWST) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:00AM	Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT (Business Wire)
Feb-02-24 11:42PM	Q1 2024 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents) +10.01%
07:55AM	Twist Bioscience Corp Reports Strong Revenue Growth in Q1 Fiscal 2024 (GuruFocus.com)
07:36AM	Twist Bioscience: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results (Business Wire)
Jan-24-24 08:00AM	Twist Bioscience Expands Express Genes Rapid Synthesis Service (Business Wire) -5.03%
Jan-16-24 08:00AM	Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024 (Business Wire)
Jan-08-24 08:00AM	Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Jan-05-24 08:00AM	Twist Bioscience Appoints Adam Laponis as Chief Financial Officer (Business Wire)
Dec-19-23 12:44PM	3 Genomics Stocks to Unlock the Future of Medicine (InvestorPlace) +10.91%
Dec-18-23 08:00AM	Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-15-23 08:11AM	Twist Bioscience (TWST) Soars 12.5%: Is Further Upside Left in the Stock? (Zacks)
Nov-20-23 08:55AM	Twist Bioscience Corporation (NASDAQ:TWST) Q4 2023 Earnings Call Transcript (Insider Monkey)
Nov-18-23 01:29AM	Q4 2023 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-17-23 04:03PM	DNA-Maker Twist Bioscience Catapults 26% On 'Solid' Outlook That Tops Its Peers (Investor's Business Daily) +25.90%
08:40AM	Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:28AM	Twist Bioscience Corp (TWST) Reports 20% Revenue Growth in Fiscal 2023 (GuruFocus.com)
07:47AM	Twist Bioscience: Fiscal Q4 Earnings Snapshot (Associated Press Finance)

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WERNER ROBERT F.	Officer	Feb 03 '25	Proposed Sale	49.35	185	9,130		Feb 03 03:24 PM
Leproust Emily M.	Officer	Feb 03 '25	Proposed Sale	49.35	5,200	256,630		Feb 03 03:23 PM
Green Paula	Officer	Feb 03 '25	Proposed Sale	49.35	1,259	62,134		Feb 03 03:18 PM
Finn Patrick John	Officer	Feb 03 '25	Proposed Sale	49.35	2,845	140,406		Feb 03 03:18 PM
Cho Dennis	Officer	Feb 03 '25	Proposed Sale	49.35	806	39,778		Feb 03 03:08 PM
Finn Patrick John	President and COO	Jan 23 '25	Sale	50.17	2,422	121,501	272,044	Jan 27 04:05 PM
Finn Patrick John	Officer	Jan 23 '25	Proposed Sale	50.17	2,422	121,501		Jan 23 03:18 PM
Laponis Adam	Chief Financial Officer	Jan 10 '25	Sale	43.26	5,886	254,646	110,096	Jan 14 04:05 PM
CHESS ROBERT	Director	Jan 07 '25	Sale	50.00	5,000	250,000	16,641	Jan 10 04:05 PM
Laponis Adam	Officer	Jan 10 '25	Proposed Sale	43.26	5,886	254,645		Jan 10 03:15 PM
Cho Dennis	See Remarks	Jan 03 '25	Sale	45.59	144	6,565	113,027	Jan 07 05:47 PM
Finn Patrick John	President and COO	Jan 03 '25	Sale	45.59	229	10,440	274,466	Jan 07 05:47 PM
Green Paula	SVP of Human Resources	Jan 03 '25	Sale	45.59	160	7,295	133,273	Jan 07 05:46 PM
Leproust Emily M.	Chief Executive Officer	Jan 03 '25	Sale	45.59	546	24,893	672,518	Jan 07 05:45 PM
Chess Robert Bruce	Director	Jan 07 '25	Proposed Sale	50.00	5,000	250,000		Jan 07 12:09 PM
Leproust Emily M.	Officer	Jan 03 '25	Proposed Sale	45.59	546	24,893		Jan 03 04:17 PM
Cho Dennis	Officer	Jan 03 '25	Proposed Sale	45.59	144	6,565		Jan 03 03:55 PM
Green Paula	Officer	Jan 03 '25	Proposed Sale	45.59	160	7,295		Jan 03 03:41 PM
Finn Patrick John	Officer	Jan 03 '25	Proposed Sale	45.59	229	10,440		Jan 03 03:26 PM
CHESS ROBERT	Director	Dec 05 '24	Option Exercise	8.82	3,504	30,905	25,145	Dec 30 04:55 PM
CHESS ROBERT	Director	Dec 05 '24	Sale	51.85	3,504	181,696	21,641	Dec 30 04:55 PM
Cho Dennis	See Remarks	Dec 20 '24	Sale	44.90	316	14,189	113,171	Dec 26 04:05 PM
Green Paula	SVP of Human Resources	Dec 20 '24	Sale	44.90	282	12,663	133,433	Dec 26 04:05 PM
Leproust Emily M.	Chief Executive Officer	Dec 20 '24	Sale	44.90	1,654	74,270	673,064	Dec 26 04:05 PM
Green Paula	Officer	Dec 20 '24	Proposed Sale	44.90	282	12,663		Dec 20 03:39 PM
Cho Dennis	Officer	Dec 20 '24	Proposed Sale	44.90	316	14,189		Dec 20 03:16 PM
Leproust Emily M.	Officer	Dec 20 '24	Proposed Sale	44.90	1,654	74,270		Dec 20 03:16 PM
Cho Dennis	See Remarks	Dec 16 '24	Sale	46.81	133	6,225	113,487	Dec 18 04:05 PM
Cho Dennis	Officer	Dec 16 '24	Proposed Sale	46.81	133	6,225		Dec 16 03:35 PM
Cho Dennis	See Remarks	Dec 06 '24	Sale	52.70	367	19,342	113,620	Dec 10 04:05 PM
Green Paula	SVP of Human Resources	Dec 06 '24	Sale	52.70	860	45,325	133,715	Dec 10 04:05 PM
Leproust Emily M.	Chief Executive Officer	Dec 06 '24	Sale	52.70	2,216	116,792	674,718	Dec 10 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Dec 06 '24	Sale	52.70	226	11,911	53,043	Dec 10 04:05 PM
Cho Dennis	Officer	Dec 06 '24	Proposed Sale	52.70	367	19,342		Dec 06 03:29 PM
Green Paula	Officer	Dec 06 '24	Proposed Sale	52.70	860	45,326		Dec 06 03:26 PM
Leproust Emily M.	Officer	Dec 06 '24	Proposed Sale	52.70	2,216	116,793		Dec 06 03:25 PM
WERNER ROBERT F.	Officer	Dec 06 '24	Proposed Sale	52.70	226	11,911		Dec 06 03:20 PM
CHESS ROBERT	Director	Dec 05 '24	Proposed Sale	51.85	3,504	181,696		Dec 05 03:19 PM
WERNER ROBERT F.	Chief Accounting Officer	Nov 25 '24	Sale	44.20	789	34,871	44,831	Nov 27 04:05 PM
WERNER ROBERT F.	Officer	Nov 25 '24	Proposed Sale	44.20	789	34,871		Nov 25 03:17 PM
CHESS ROBERT	Director	Nov 11 '24	Option Exercise	8.82	3,600	31,752	25,241	Nov 13 08:30 PM
CHESS ROBERT	Director	Nov 11 '24	Sale	47.26	3,600	170,139	21,641	Nov 13 08:30 PM
Cho Dennis	See Remarks	Nov 11 '24	Sale	48.00	1,507	72,333	91,163	Nov 13 05:24 PM
Finn Patrick John	President and COO	Nov 11 '24	Sale	48.00	10,340	496,299	221,061	Nov 13 05:24 PM
Green Paula	SVP of Human Resources	Nov 11 '24	Sale	48.00	1,347	64,653	114,147	Nov 13 05:23 PM
Leproust Emily M.	Chief Executive Officer	Nov 11 '24	Sale	48.00	7,968	382,448	581,584	Nov 13 05:23 PM
Finn Patrick John	Officer	Nov 11 '24	Proposed Sale	48.00	10,340	496,294		Nov 12 10:23 AM
Leproust Emily M.	Officer	Nov 11 '24	Proposed Sale	48.00	7,968	382,444		Nov 12 10:04 AM
Green Paula	Officer	Nov 11 '24	Proposed Sale	48.00	1,347	64,653		Nov 12 09:53 AM
Cho Dennis	Officer	Nov 11 '24	Proposed Sale	48.00	1,507	72,332		Nov 12 09:43 AM
Leproust Emily M.	Chief Executive Officer	Nov 06 '24	Sale	44.60	14,334	639,368	589,552	Nov 08 04:05 PM
Green Paula	SVP of Human Resources	Nov 06 '24	Sale	44.60	5,519	246,175	115,494	Nov 08 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Nov 06 '24	Sale	44.60	1,448	64,588	45,620	Nov 08 04:05 PM
Laponis Adam	Chief Financial Officer	Nov 06 '24	Sale	44.60	4,160	185,557	89,237	Nov 08 04:05 PM
Finn Patrick John	President and COO	Nov 06 '24	Sale	44.60	6,239	278,291	231,401	Nov 08 04:05 PM
Cho Dennis	See Remarks	Nov 06 '24	Sale	44.60	1,811	80,780	92,670	Nov 08 04:05 PM
Leproust Emily M.	Officer	Nov 06 '24	Proposed Sale	44.60	14,334	639,365		Nov 06 05:36 PM
Laponis Adam	Officer	Nov 06 '24	Proposed Sale	44.60	4,160	185,556		Nov 06 05:24 PM
WERNER ROBERT F.	Officer	Nov 06 '24	Proposed Sale	44.60	1,448	64,588		Nov 06 05:14 PM
Green Paula	SVP of Human Resources	Nov 04 '24	Sale	41.56	1,057	43,933	121,013	Nov 06 05:06 PM
Cho Dennis	See Remarks	Nov 04 '24	Sale	41.56	659	27,391	94,481	Nov 06 05:06 PM
Leproust Emily M.	Chief Executive Officer	Nov 04 '24	Sale	41.56	4,841	201,211	603,886	Nov 06 05:06 PM
Finn Patrick John	President and COO	Nov 04 '24	Sale	41.56	2,681	111,433	237,640	Nov 06 05:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Nov 04 '24	Sale	41.56	156	6,484	47,068	Nov 06 05:05 PM
Green Paula	Officer	Nov 06 '24	Proposed Sale	44.60	5,519	246,174		Nov 06 04:12 PM
Cho Dennis	Officer	Nov 06 '24	Proposed Sale	44.60	1,811	80,779		Nov 06 03:57 PM
WERNER ROBERT F.	Officer	Nov 06 '24	Proposed Sale	44.60	1,448	64,588		Nov 06 03:46 PM
Finn Patrick John	Officer	Nov 06 '24	Proposed Sale	44.60	6,239	278,289		Nov 06 03:34 PM
Leproust Emily M.	Officer	Nov 04 '24	Proposed Sale	41.56	4,841	201,212		Nov 04 03:44 PM
Green Paula	Officer	Nov 04 '24	Proposed Sale	41.56	1,057	43,933		Nov 04 03:44 PM
Cho Dennis	Officer	Nov 04 '24	Proposed Sale	41.56	659	27,391		Nov 04 03:37 PM
WERNER ROBERT F.	Officer	Nov 04 '24	Proposed Sale	41.56	156	6,484		Nov 04 03:26 PM
Finn Patrick John	Officer	Nov 04 '24	Proposed Sale	41.56	2,681	111,433		Nov 04 03:15 PM
Finn Patrick John	President and COO	Oct 23 '24	Sale	43.09	2,261	97,429	159,483	Oct 25 04:05 PM
Finn Patrick John	Officer	Oct 23 '24	Proposed Sale	43.09	2,261	97,429		Oct 23 03:28 PM
Laponis Adam	Chief Financial Officer	Oct 09 '24	Sale	41.81	856	35,791	73,397	Oct 11 04:05 PM
Laponis Adam	Officer	Oct 09 '24	Proposed Sale	41.81	856	35,791		Oct 09 03:12 PM
Green Paula	SVP of Human Resources	Oct 02 '24	Sale	43.21	3,310	143,028	84,585	Oct 04 04:05 PM
Leproust Emily M.	Chief Executive Officer	Oct 02 '24	Sale	43.21	13,605	587,886	481,918	Oct 04 04:05 PM
Finn Patrick John	President and COO	Oct 02 '24	Sale	43.21	6,865	296,644	161,744	Oct 04 04:05 PM
Cho Dennis	See Remarks	Oct 02 '24	Sale	43.21	3,104	134,127	75,289	Oct 04 04:05 PM
Green Paula	Officer	Oct 02 '24	Proposed Sale	43.21	3,310	143,027		Oct 02 05:01 PM
Cho Dennis	Officer	Oct 02 '24	Proposed Sale	43.21	3,104	134,126		Oct 02 04:44 PM
Leproust Emily M.	Officer	Oct 02 '24	Proposed Sale	43.21	13,605	587,880		Oct 02 04:36 PM
Finn Patrick John	Officer	Oct 02 '24	Proposed Sale	43.21	6,865	296,641		Oct 02 04:33 PM
Cho Dennis	See Remarks	Sep 20 '24	Sale	46.94	234	10,984	78,393	Sep 24 04:05 PM
Green Paula	SVP of Human Resources	Sep 20 '24	Sale	46.94	297	13,941	87,895	Sep 24 04:05 PM
Leproust Emily M.	Chief Executive Officer	Sep 20 '24	Sale	46.94	1,730	81,208	495,523	Sep 24 04:05 PM
Green Paula	Officer	Sep 20 '24	Proposed Sale	46.94	297	13,941		Sep 20 03:29 PM
Leproust Emily M.	Officer	Sep 20 '24	Proposed Sale	46.94	1,730	81,208		Sep 20 03:28 PM
Cho Dennis	Officer	Sep 20 '24	Proposed Sale	46.94	234	10,984		Sep 20 03:08 PM
Cho Dennis	See Remarks	Sep 16 '24	Sale	46.42	94	4,364	78,627	Sep 18 04:05 PM
Cho Dennis	Officer	Sep 16 '24	Proposed Sale	46.42	94	4,364		Sep 16 03:33 PM
Cho Dennis	See Remarks	Sep 06 '24	Sale	39.16	275	10,769	78,721	Sep 10 04:04 PM
Green Paula	SVP of Human Resources	Sep 06 '24	Sale	39.16	912	35,715	88,192	Sep 10 04:03 PM
WERNER ROBERT F.	Chief Accounting Officer	Sep 06 '24	Sale	39.16	240	9,399	38,724	Sep 10 04:03 PM
Leproust Emily M.	Chief Executive Officer	Sep 06 '24	Sale	39.16	2,340	91,637	497,253	Sep 10 04:03 PM
WERNER ROBERT F.	Officer	Sep 06 '24	Proposed Sale	39.16	240	9,399		Sep 06 03:27 PM
Green Paula	Officer	Sep 06 '24	Proposed Sale	39.16	912	35,715		Sep 06 03:26 PM
Cho Dennis	Officer	Sep 06 '24	Proposed Sale	39.16	275	10,769		Sep 06 03:19 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TWST

Twist Bioscience Corp

Upgrade your FINVIZ experience